Full Text Journal Articles by
Author David Stroncek

Advertisement

Find full text journal articles






Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases.

Lipei Shao, Alejandra Pelayo, Rongye Shi, Jinxia Ma, Hui Liu, Yihua Cai, Michaela Prochazkova, Robert P Somerville, Sandhya R Panch, Nirali N Shah, David F Stroncek, Ping Jin,

<h4>Background</h4>Cytokine release syndrome (CRS) is a strong immune system response that can occur as a result of the reaction of a cellular immunotherapy with malignant cells. While the frequency and management of CRS in CAR T-cell therapy has been well documented, there is emerging interest in pre-emptive treatment to reduce ... Read more >>

J Transl Med (Journal of translational medicine)
[2022, 20(1):338]

Cited: 0 times

View full text PDF listing >>



CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.

Haneen Shalabi, Haiying Qin, Angela Su, Bonnie Yates, Pamela L Wolters, Seth M Steinberg, John A Ligon, Sara Silbert, Kniya DéDé, Mehdi Benzaoui, Sophia Goldberg, Sooraj Achar, Dina Schneider, Shilpa A Shahani, Lauren Little, Toni Foley, John C Molina, Sandhya Panch, Crystal L Mackall, Daniel W Lee, Christopher D Chien, Marie Pouzolles, Mark Ahlman, Constance M Yuan, Hao-Wei Wang, Yanyu Wang, Jon Inglefield, Mary Anne Toledo-Tamula, Staci Martin, Steven L Highfill, Gregoire Altan-Bonnet, David Stroncek, Terry J Fry, Naomi Taylor, Nirali N Shah,

Remission durability following single-antigen targeted chimeric antigen receptor (CAR) T-cells is limited by antigen modulation, which may be overcome with combinatorial targeting. Building upon our experiences targeting CD19 and CD22 in B-cell acute lymphoblastic leukemia (B-ALL), we report on our phase 1 dose-escalation study of a novel murine stem cell ... Read more >>

Blood (Blood)
[2022, 140(5):451-463]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.5587 s